LUPIN
|
The Current P/E Ratio of LUPIN is 40.52.
Share Price | ₹1,609.2 | Apr 16,2024 |
Market Cap | ₹73,331.2 Cr | |
Earnings-TTM | ₹1,809.7 Cr | TTM-Consolidated Results |
Price/Earnings | 40.52x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of LUPIN
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹73,331.2 Cr] as on Apr 16,2024
(/) Earnings [ ₹1,809.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 40.52x ]
Thus, for LUPIN , the investors are currently willing to pay 40.52 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of LUPIN !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of LUPIN over the last five years.
Historical PE (Price/Earnings) ratio chart of LUPIN
PE Ratio Performance Analysis for LUPIN
- LUPIN 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 32.35x.
- LUPIN 's operated at median p/e ratio of 38.08x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LUPIN 's p/e ratio peaked in Mar2023 at 68.54x.
- LUPIN 's p/e ratio hit its five-year low in Mar2022 of 0x.
How does LUPIN 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
LUPIN | 1,809.74 | 40.52 | 73,331.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 8,998.63 | 40.98 | 368,766.0 |
CIPLA LTD | 3,744.03 | 29.67 | 111,102.0 |
DR REDDYS LABORATORIES LTD | 5,209.40 | 19.38 | 100,958.0 |
ZYDUS LIFESCIENCES LTD | 2,954.20 | 32.19 | 95,104.2 |
DIVIS LABORATORIES LTD | 1,382.97 | 72.26 | 99,939.6 |
MANKIND PHARMA LTD | 1,743.30 | 52.44 | 91,420.3 |
TORRENT PHARMACEUTICALS LTD | 1,494.00 | 57.46 | 85,851.8 |
AUROBINDO PHARMA LTD | 2,777.89 | 23.41 | 65,027.5 |
ABBOTT INDIA LTD | 1,145.58 | 48.40 | 55,442.3 |
ALKEM LABORATORIES LTD | 1,574.66 | 35.95 | 56,605.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs LUPIN 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 19.38x |
Max industry PE | 72.26x |
Median industry PE | 40.52x |
Average industry PE | 41.15x |
You may also like the below Video Courses